This Briefing outlines the benefits of better managing the commercial determinants of health in Aotearoa New Zealand (NZ). It was prompted by the World Health Organization (WHO) report on how commercial entities are increasingly shaping public policy and health outcomes. This growing influence often leads to negative health impacts, particularly among vulnerable populations.
In NZ, recent policy decisions show a pattern of prioritizing commercial interests over public health, particularly in sectors like transport, alcohol, tobacco, and infant formula. These cases have sparked concern among health experts, who argue that such influence undermines public well-being and calls into question the integrity of policymaking.
Measures to address these concerns include more transparent governance, stricter political donation rules, a lobbying register, and a clear code of conduct. Additionally, the “revolving door” between government and industry needs to be shut to prevent conflicts of interest.
The authors argue that the NZ Government needs to explain how it will implement the WHO’s guidance and protect public health from undue commercial influence. One upside is the positive potential of the private sector in promoting health.